Charles Schwab’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Buy
200,059
+4,488
+2% +$42.6K ﹤0.01% 2795
2026
Q1
$1.67M Sell
195,571
-6,913
-3% -$62K ﹤0.01% 2761
2025
Q4
$1.79M Sell
202,484
-105
-0.1% -$1.21K ﹤0.01% 2780
2025
Q3
$2.68M Buy
202,589
+144,049
+246% +$1.8M ﹤0.01% 2679
2025
Q2
$800K Buy
58,540
+1,285
+2% +$17.3K ﹤0.01% 2969
2025
Q1
$787K Buy
57,255
+28,650
+100% +$418K ﹤0.01% 2924
2024
Q4
$489K Hold
28,605
﹤0.01% 3145
2024
Q3
$526K Buy
+28,605
New +$505K ﹤0.01% 3140

Other funds holding ARDT

Charles Schwab's ARDT Position: Q2 2026 in Review

Charles Schwab increased its Ardent Health (ARDT) stake by 2.3% in Q2 2026, buying an estimated $42.6K and bringing the position to 200,059 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2795.

Charles Schwab first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.68M in Q3 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Charles Schwab held 200,059 shares of Ardent Health worth $1.97M as of Q2 2026.
  • Charles Schwab bought 4,488 Ardent Health shares in Q2 2026, an estimated $42.6K.
  • Ardent Health made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2795 holding.
  • Charles Schwab first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • Charles Schwab's Ardent Health position peaked at $2.68M in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.